Overview
- 261 inspections across 244 sites are on record.
- 309 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-08.
At a glance
Inspections
261
Sites
244
Observations
309
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Alvotech HF | 8 May 2026 | Human Drugs | On file |
| Similasan AG | 27 Apr 2026 | Human Drugs | On file |
| EUGIA Pharma Specialities Limited | 27 Feb 2026 | Human Drugs | On file |
| Apitoria Pharma Private Limited | 12 Dec 2025 | Human Drugs | On file |
| Glenmark Pharmaceuticals Limited | 28 Nov 2025 | Human Drugs |
Sites inspected
Alvotech HFReykjavik, Iceland1 insp.
Similasan AGJonen, Switzerland1 insp.
EUGIA Pharma Specialities LimitedMedchal-Malkajgiri District, India1 insp.
Apitoria Pharma Private LimitedPashamylaram, India1 insp.
Glenmark Pharmaceuticals LimitedAurangabad, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Jazmine N Still8 shared
Chunchang Fang8 shared
Chiang Syin4 shared
Darren S Morgan3 shared
Gang Wang3 shared
Dennis Cantellops Paite3 shared
Randy L Self3 shared
Saleem A Akhtar2 shared
Travis V Hull2 shared
Tyler M Peterson2 shared
Full investigator report
Get the verbatim findings behind Matthew B Casale's 309 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site